Compare Dell Technologies Inc (DELL) vs Novartis AG (NVS) Price & Performance

Dell Technologies IncTrade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

Dell Technologies Inc vs Novartis AG — how do they compare? Dell Technologies Inc trades at $450.6 (market cap $284.93B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Dell Technologies Inc and Novartis AG are close in size by market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.

	DELL	NVS
Market Cap	$284.93B	$295.37B
Sector	Technology	Health
52-Week High	$467.27	$168.62
52-Week Low	$111.10	$119.31
Enterprise Value	$304.51B	$336.69B
Dividend Yield	0.57%	3.07%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DELL

AI infrastructure leaders Micron, Super Micro, and Dell show strong growth and upside potential into 2027.24/7 Wall Street · 1 day agoBullish Super Micro shares rise 4% ahead of Q4 earnings on strong margin outlook and $60B backlog.24/7 Wall Street · 2 days agoBullish Super Micro Computer stock trades 21% below target amid export-control audit and $60B AI server backlog.24/7 Wall Street · 2 days agoBullish View details →

NVS

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.24/7 Wall Street · 1 day agoBullish View details →

About Dell Technologies Inc

VMware is an industry titan in virtualizing IT infrastructure and became a stand-alone entity after spinning off from Dell Technologies in November 2021. The software provider operates in the three segments: licenses

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.